melphalan,busulfan,bortezomib,lenalidomide,dexamethasone
Otsuka America Pharmaceutical,Takeda
busulfan/melphalan prior to asct fails to elicit pfs benefit in newly diagnosed myeloma #ims2022 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.